Associate Professor, Medicine, University of California Los Angeles David Geffen SOM
Cardiology
Dr. Tamara B. Horwich, MD
|
|
Give Review
Tamara B. Horwich works in the field of Cardiology. She attended Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. She received 3 awards: "Fellow (FAHA)", "Fellow (FACC)" and "Super Doctor". Tamara Horwich is a published physician. She published 64 publications, including: 'mRNA from frog corneal epithelium increases water permeability in Xenopus oocytes.' Dr. Tamara B. Horwich accepts all Medicare patients.
Publications
- Inflammatory Mediators and Clinical Outcome in Patients With Advanced Heart Failure Receiving Cardiac Resynchronization Therapy.
- Obesity and the obesity paradox in Heart failure.
- Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic Heart failure.
- Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis.
- Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic Syndrome.
- Age at menopause and incident Heart failure: the Multi-Ethnic Study of Atherosclerosis.
- Four-Variable Risk Model in Men and Women with Heart Failure.
- Heart Failure is Associated With Impaired Anti-Inflammatory and Antioxidant Properties of High-Density Lipoproteins.
- Pro-Heart - A Randomized Clinical Trial to Test the Effectiveness of a High Protein Diet Targeting Obese Individuals with Heart Failure: Rationale, Design and Baseline...
- Obesity in Heart failure: impact on survival and treatment modalities.
- Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced Heart failure patients on optimal medical and device therapy.
- Temporal Trends in Treatment and Outcomes for Advanced Heart Failure with Reduced Ejection Fraction from 1993-2010: Findings from a University Referral Center.
- The Obesity Paradox in Men Versus Women With Systolic Heart Failure.
- Effect of Bioimpedance Body Composition Analysis on Function of Implanted Cardiac Devices.
- Relation Between Hemoglobin A(1c) and Outcomes in Heart Failure Patients With and Without Diabetes Mellitus.
- Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic Heart failure: a double-blind placebo-controlled trial.
- Relation Among Body Mass Index, Exercise Training, and Outcomes in Chronic Systolic Heart Failure.
- Waist circumference, body mass index, and survival in systolic Heart failure: the obesity paradox revisited.
- Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced Heart failure.
- Metformin therapy and outcomes in patients with advanced systolic Heart failure and diabetes.
- Glucose, obesity, metabolic Syndrome, and diabetes relevance to incidence of heart failure.
- Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.
- Relation of systolic blood pressure to survival in both ischemic and nonischemic systolic Heart failure.
- Cholesterol levels and in-hospital mortality in patients with Acute decompensated heart failure.
- Measures of obesity and outcomes after Myocardial infarction.
- Nutritional and anti-inflammatory interventions in Chronic heart failure.
- Albumin levels predict survival in patients with systolic Heart failure.
- Potential autonomic nervous system effects of statins in Heart failure.
- Reverse epidemiology beyond dialysis patients: Chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS.
- Tipping the scale: Heart failure, body mass index, and prognosis.
- Total cholesterol levels and mortality risk in nonischemic systolic Heart failure.
- Relation of loop diuretic dose to mortality in advanced Heart failure.
- Epidemiology of dialysis patients and Heart failure patients.
- B-type natriuretic peptide levels in obese patients with advanced Heart failure.
- An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic Heart failure.
- Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced Heart failure.
- Obesity paradox as a component of reverse epidemiology in Heart failure.
- Survival advantages of obesity in dialysis patients.
- Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced Heart failure.
- Statin therapy is associated with improved survival in ischemic and non-ischemic Heart failure.
- Cholesterol and mortality in Heart failure: the bad gone good?
- Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced Heart failure.
- Combining natriuretic peptides and necrosis markers in determining prognosis in Heart failure.
- Prevention of Heart failure: effective strategies to combat the growing epidemic.
- Low serum total cholesterol is associated with marked increase in mortality in advanced Heart failure.
- Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced Heart failure.
- Prevention of Heart failure.
- Epidemiology and risk profile of Heart failure.
- Weekend hospital admission and discharge for Heart failure: association with quality of care and clinical outcomes.
- The relationship between body mass index and cardiopulmonary exercise testing in Chronic systolic heart failure.
- Influence of hospital length of stay for Heart failure on quality of care.
- Atorvastatin and statins in the treatment of Heart failure.
- Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
- Racial and survival paradoxes in chronic kidney Disease.
- Risk factor paradox in wasting Diseases.
- The relationship between obesity and mortality in patients with Heart failure.
- The impact of obesity on survival in patients with Heart failure.
- Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies.
- Reverse epidemiology of conventional cardiovascular risk factors in patients with Chronic heart failure.
- Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer.
- Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.
- Low-density lipoprotein in the setting of congestive Heart failure: is lower really better?
- mRNA from frog corneal epithelium increases water permeability in Xenopus oocytes.
Schools
Columbia University College Of Physicians and Surgeons
UCLA Med CtrUCLA D Geffen School
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioversion, Elective
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FAHA)
- Fellow (FACC)
- Super Doctor
Education
-
UCLA Medical Center -
Columbia University College of Physicians & Surgeons
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1346281748 | |
| NPPES Provider LastName | HORWICH | |
| NPPES Provider FirstName | TAMARA | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 497.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346281748 |
| Last Name Of The Provider | HORWICH |
| First Name Of The Provider | TAMARA |
| View All |
Similar Doctors
|
|
Dr. Faye M. Montegrande, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Goodman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald S. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Il Y. Kim, MD |
|
|
Dr. Jesus A. Araujo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda X. Fong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald M. Pohost, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prashant S. Patel, MD |
|
|
Dr. Gary Reznik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjay Kaul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry M. Honda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Cole, MD |
|
|
Dr. Garo Z. Pehlevanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kim-Lien T. Nguyen, MD |